- Home
- PRCH vs CLDX Comparison
PRCH vs CLDX Comparison
Compare PRCH & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCH
- CLDX
- Stock Information
- Founded
- PRCH 2012
- CLDX N/A
- Country
- PRCH United States
- CLDX United States
- Employees
- PRCH N/A
- CLDX N/A
- Industry
- PRCH Computer Software: Prepackaged Software
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PRCH Technology
- CLDX Health Care
- Exchange
- PRCH Nasdaq
- CLDX Nasdaq
- Market Cap
- PRCH 1.6B
- CLDX 1.6B
- IPO Year
- PRCH N/A
- CLDX 2008
- Fundamental
- Price
- PRCH $17.44
- CLDX $24.45
- Analyst Decision
- PRCH Strong Buy
- CLDX Strong Buy
- Analyst Count
- PRCH 10
- CLDX 9
- Target Price
- PRCH $15.80
- CLDX $46.13
- AVG Volume (30 Days)
- PRCH 2.1M
- CLDX 1.6M
- Earning Date
- PRCH 11-06-2025
- CLDX 11-05-2025
- Dividend Yield
- PRCH N/A
- CLDX N/A
- EPS Growth
- PRCH N/A
- CLDX N/A
- EPS
- PRCH 0.52
- CLDX N/A
- Revenue
- PRCH $435,601,000.00
- CLDX $5,790,000.00
- Revenue This Year
- PRCH N/A
- CLDX N/A
- Revenue Next Year
- PRCH $18.56
- CLDX N/A
- P/E Ratio
- PRCH $33.37
- CLDX N/A
- Revenue Growth
- PRCH N/A
- CLDX N/A
- 52 Week Low
- PRCH $1.16
- CLDX $14.40
- 52 Week High
- PRCH $19.22
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- PRCH 57.27
- CLDX 57.32
- Support Level
- PRCH $17.65
- CLDX $22.44
- Resistance Level
- PRCH $19.22
- CLDX $25.51
- Average True Range (ATR)
- PRCH 0.80
- CLDX 1.22
- MACD
- PRCH -0.04
- CLDX 0.23
- Stochastic Oscillator
- PRCH 48.33
- CLDX 74.58
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.